Royal Bank Of Canada Immix Biopharma, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,000 shares of IMMX stock, worth $3,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 84,000
97.62%
Holding current value
$3,520
Previous $125,000
96.8%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMMX
# of Institutions
28Shares Held
3.3MCall Options Held
11.5KPut Options Held
900-
Bleichroeder LP New York, NY850KShares$1.5 Million0.6% of portfolio
-
Cable Car Capital LLC San Francisco, CA796KShares$1.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA699KShares$1.23 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$712,80011.13% of portfolio
-
Geode Capital Management, LLC Boston, MA150KShares$264,1440.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $24.5M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...